Construction and validation of chemoresistance-associated tumor- infiltrating exhausted-like CD8+ T cell signature in breast cancer: cr-TILCD8TSig.

Frontiers in immunology（2023）

引用 0|浏览1

暂无评分

摘要

cr-TILCD8TSig is a useful tool to independently predict prognosis, chemotherapy response, and immunotherapy outcomes in patients with breast cancer.

查看译文

关键词

chemoresistance,immunotherapy,prognosis,signature,tumor-infiltrating CD8+ T cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要